<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/2021.09.25.461800</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;2021.09.25.461800</article-id><article-id pub-id-type="other" hwp:sub-type="slug">2021.09.25.461800</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">2021.09.25.461800</article-id><article-id pub-id-type="other" hwp:sub-type="tag">2021.09.25.461800</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Microbiology" hwp:journal="biorxiv"><subject>Microbiology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">High-level carbapenem tolerance requires antibiotic-induced outer membrane modifications</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2"><label>#</label>corresponding authors: <email hwp:id="email-1">tdoerr@cornell.edu</email>, <email hwp:id="email-2">joseph.boll@uta.edu</email></corresp><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2"><label>*</label><p hwp:id="p-1">contributed equally</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6415-8718</contrib-id><name name-style="western" hwp:sortable="Murtha Andrew N."><surname>Murtha</surname><given-names>Andrew N.</given-names></name><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">*</xref><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-6415-8718"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Kazi Misha I."><surname>Kazi</surname><given-names>Misha I.</given-names></name><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">*</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Schargel Richard D."><surname>Schargel</surname><given-names>Richard D.</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Cross Trevor"><surname>Cross</surname><given-names>Trevor</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Fihn Conrad"><surname>Fihn</surname><given-names>Conrad</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Carlson Erin E."><surname>Carlson</surname><given-names>Erin E.</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-7"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1412-9780</contrib-id><name name-style="western" hwp:sortable="Boll Joseph M."><surname>Boll</surname><given-names>Joseph M.</given-names></name><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">#</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-1412-9780"/></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-8"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3283-9161</contrib-id><name name-style="western" hwp:sortable="Dörr Tobias"><surname>Dörr</surname><given-names>Tobias</given-names></name><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">#</xref><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-3283-9161"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3"><label>1</label><institution hwp:id="institution-1">Weill Institute for Cell and Molecular Biology, Cornell University</institution>, Ithaca, NY 14853, <country>USA</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3"><label>2</label><institution hwp:id="institution-2">Department of Microbiology, Cornell University</institution>, Ithaca NY 14853, <country>USA</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3"><label>3</label><institution hwp:id="institution-3">Department of Biology, University of Texas Arlington</institution>, Arlington, TX, <country>USA</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2"><label>4</label><institution hwp:id="institution-4">Department of Medicinal Chemistry, University of Minnesota</institution>, Minneapolis, Minnesota 55454, <country>USA</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1"><label>5</label><institution hwp:id="institution-5">Department of Chemistry, University of Minnesota</institution>, Minneapolis, Minnesota 55455, <country>USA</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1"><label>6</label><institution hwp:id="institution-6">Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota</institution>, Minneapolis, Minnesota 55454, <country>USA</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1"><label>7</label><institution hwp:id="institution-7">Department of Molecular Pharmacology and Therapeutics, University of Minnesota</institution>, Minneapolis, Minnesota 55454, <country>USA</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1"><label>8</label><institution hwp:id="institution-8">Cornell Institute of Host-Microbe Interactions and Disease, Cornell University</institution>, Ithaca NY 14853, <country>USA</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2021-09-26T04:21:18-07:00">
    <day>26</day><month>9</month><year>2021</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-10-22T13:51:10-07:00">
    <day>22</day><month>10</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2021-09-26T04:26:49-07:00">
    <day>26</day><month>9</month><year>2021</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-10-22T13:56:42-07:00">
    <day>22</day><month>10</month><year>2021</year>
  </pub-date><elocation-id>2021.09.25.461800</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2021-09-25"><day>25</day><month>9</month><year>2021</year></date>
<date date-type="rev-recd" hwp:start="2021-10-22"><day>22</day><month>10</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-10-22"><day>22</day><month>10</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-2">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="461800.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/2021.09.25.461800v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="461800.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/2021.09.25.461800v2/2021.09.25.461800v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/2021.09.25.461800v2/2021.09.25.461800v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-3">Antibiotic tolerance is an understudied potential contributor to antibiotic treatment failure and the emergence of multidrug-resistant bacteria. The molecular mechanisms governing tolerance remain poorly understood. A prominent type of β-lactam tolerance relies on the formation of cell wall-deficient spheroplasts, which maintain structural integrity via their outer membrane (OM), an asymmetric lipid bilayer consisting of phospholipids on the inner leaflet and a lipid-linked polysaccharide (lipopolysaccharide, LPS) enriched in the outer monolayer on the cell surface. How a membrane structure like LPS, with its reliance on mere electrostatic interactions to maintain stability, is capable of countering internal turgor pressure is unknown. Here, we have uncovered a novel role for the PhoPQ two-component system in tolerance to the β-lactam antibiotic meropenem in Enterobacterales. We found that PhoPQ is induced by meropenem treatment and promotes an increase in 4-amino-4-deoxy-L-aminoarabinose [L-Ara4N] modification of lipid A, the membrane anchor of LPS. L-Ara4N modifications enhance structural integrity, and consequently tolerance to meropenem, in several Enterobacterales species. Importantly, mutational inactivation of the negative PhoPQ regulatory element <italic toggle="yes">mgrB</italic> (commonly selected for during clinical therapy with the last-resort antibiotic colistin, an antimicrobial peptide [AMP]) results in dramatically enhanced tolerance, suggesting that AMPs can collaterally select for meropenem tolerance via stable overactivation of PhoPQ. Lastly, we identify histidine kinase inhibitors (including an FDA-approved drug) that inhibit PhoPQ-dependent LPS modifications and consequently potentiate meropenem to enhance killing of tolerant cells. In summary, our results suggest that PhoPQ-mediated LPS modifications play a significant role in stabilizing the OM, promoting survival when the primary integrity maintenance structure, the cell wall, is removed.</p><sec hwp:id="sec-1"><title hwp:id="title-2">Significance</title><p hwp:id="p-4">Treating an infection with an antibiotic often fails, resulting in a tremendous public health burden. One understudied likely reason for treatment failure is the development of “antibiotic tolerance”, the ability of bacteria to survive normally lethal exposure to an antibiotic. Here, we describe a molecular mechanism promoting tolerance. A bacterial stress sensor (PhoPQ) is activated in response to antibiotic (meropenem) treatment and consequently strengthens a bacterial protective “shell” to enhance survival. We also identify inhibitors of this mechanism, opening the door to developing compounds that help antibiotics work better against tolerant bacteria.</p></sec></abstract><counts><page-count count="33"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-3">Competing Interest Statement</title><p hwp:id="p-5">The authors have declared no competing interest.</p></notes></notes></front><body><sec id="s1" hwp:id="sec-2"><title hwp:id="title-4">Introduction</title><p hwp:id="p-6">The rapid rise of antibiotic treatment failure threatens our ability to prevent and control bacterial infections. Antibiotic resistance, the continued proliferation of bacteria in the presence of the antibiotic, can often explain failure of clinical therapy. However, the response to an antibiotic is oftentimes more nuanced than a simple dichotomy of resistance vs. susceptibility. Bacteria can survive treatment in a non- or slowly-proliferating state, readily reverting to healthy growth after removal of the antibiotic (such as the end of a treatment course), and this is typically referred to as “antibiotic tolerance” (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>–<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>). Importantly, tolerance to antibotics has been shown to enhance the evolution of outright resistance mechanisms (<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>–<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>), and can thus serve as both a direct and indirect contributor to treatment failure.</p><p hwp:id="p-7">β-lactams are the most widely prescribed antibiotic class used to treat bacterial infections. The β-lactam ring inhibits the activity of the penicillin-binding proteins (PBPs) through covalent modification of a catalytic residue. PBPs are enzymes that synthesize the cell wall, an essential structure composed mainly of the polysaccharide peptidoglycan (PG). In many well-studied model organisms, PBP inhibition induces cell wall degradation and often subsequent lysis through the action of cell-wall degrading enzymes (collectively referred to as “autolysins”) in a poorly-understood manner (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>). While lysis is the canonical response of model organisms like <italic toggle="yes">Escherichia coli</italic> K12, many susceptible clinical isolates of Gram-negative pathogens (including prominent Enterobacterales clinical isolates like <italic toggle="yes">Klebsiella spp</italic>. and <italic toggle="yes">Enterobacter spp</italic>.) exhibit a unique type of β-lactam tolerance. Like <italic toggle="yes">E. coli</italic>, these cells digest their PG upon exposure to β-lactams. However, instead of lysing, these pathogens survive antibiotic-induced cell wall degradation by forming viable, non-dividing, cell wall-deficient spheroplasts, which presumably rely on the outer membrane to counter their internal turgor (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>–<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>). Interestingly, spheroplasts do not absolutely require osmotic stabilization and form in diverse types of growth media, including human serum (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-2" hwp:rel-id="ref-9">9</xref>). This cell wall-deficient phenotype is reminiscent of so-called L-forms (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>–<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>), with the notable distinction that spheroplasts do not divide in the presence of the antibiotic.</p><p hwp:id="p-8">Remarkably, spheroplasts formed in response to the carbapenem antibiotic meropenem readily resume growth and revert to wild-type rod shape when the β-lactam is removed from the growth medium (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref>, <xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-3" hwp:rel-id="ref-9">9</xref>). Little is known about the molecular mechanisms that facilitate spheroplast formation and survival. In <italic toggle="yes">Vibrio cholerae</italic>, the two-component system (TCS) VxrAB is essential for spheroplast recovery by upregulating cell wall synthesis and downregulating iron uptake into the cells, mitigating toxic free iron levels induced by β-lactam treatment and allowing the cell to avoid damage by oxidative stress (<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>, <xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>). Many questions remain, however, as to how the cell envelope maintains its integrity without a cell wall, the essential structure canonically thought to protect the cell against immense turgor pressure.</p><p hwp:id="p-9">In this study, we investigated genetic factors that contribute to the ability of <italic toggle="yes">Enterobacter cloacae</italic> to tolerate meropenem, which is used as a last-resort β-lactam to treat multidrug resistant bacterial infections (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>–<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>). We first show that tolerance is dependent on outer membrane modifications (specifically 4-amino-4-deoxy-L-aminoarabinose [L-Ara4N]) induced by the PhoPQ TCS, an important cell envelope stress sensor that has previously been shown to respond to magnesium limitation, cationic antimicrobial peptide exposure, osmotic challenge, and pH changes (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>). Both PhoPQ regulon transcription and resulting lipid A modifications are induced by meropenem treatment, suggesting a specific response to perturbations of PG synthesis in <italic toggle="yes">E. cloacae</italic>. These findings represent a novel mechanism of β-lactam tolerance in clinically relevant Enterobacterales, as well as an expanded role for the PhoPQ TCS.</p></sec><sec id="s2" hwp:id="sec-3"><title hwp:id="title-5">Results</title><sec id="s2a" hwp:id="sec-4"><title hwp:id="title-6">The PhoPQ TCS system regulates carbapenem tolerance</title><p hwp:id="p-10">We previously showed that many Gram-negative pathogens are highly tolerant to meropenem. Upon treatment, tolerant cells do not appreciably lyse. Instead, they form viable, enlarged, non-replicating spheroplasts that are devoid of detectable cell wall material (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-4" hwp:rel-id="ref-9">9</xref>). Meropenem-induced spheroplast formation is quantifiable as an OD<sub>600</sub> increase (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1A</xref></bold>) and concomitant with only a moderate decrease in survival, as measured by colony-forming units (CFU) (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig. 1B</xref></bold>). In contrast, non-tolerant bacteria like many <italic toggle="yes">E. coli</italic> isolates rapidly lyse in the presence of meropenem, indicated by a decrease in both OD<sub>600</sub> and survival (<bold><xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig. 1AB</xref></bold>). Since spheroplast integrity is presumably maintained by the outer membrane, rather than the cell wall, we hypothesized that the strength of the outer membrane might correlate with tolerance. To test this, we repeated the killing experiments in the presence of the known outer membrane fortifying agents Mg<sup>2+</sup> and Ca<sup>2+</sup>, which link adjacent lipopolysaccharide molecules by forming ionic bridges between phosphate groups on the lipid A domain (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>, <xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>). Addition of either divalent cation (Mg<sup>2+</sup> and Ca<sup>2+</sup>) supported spheroplast formation with a concomitant reduction in lysis during meropenem treatment in a concentration-dependent manner (<bold><xref ref-type="fig" rid="figS1" hwp:id="xref-fig-8-1" hwp:rel-id="F8">Fig. S1AB</xref></bold>). Furthermore, combinatorial addition of excess Ca<sup>2+</sup> and Mg<sup>2+</sup> completely prevented lysis (<bold><xref ref-type="fig" rid="figS1" hwp:id="xref-fig-8-2" hwp:rel-id="F8">Fig. S1A</xref></bold>). Thus, divalent cations prevent lysis during meropenem treatment, potentially through increasing the mechanical load-bearing capacity of the outer membrane through LPS crosslinking to protect the spheroplast structure.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1:</label><caption hwp:id="caption-1"><title hwp:id="title-7"><italic toggle="yes">Enterobacter cloacae</italic> is highly meropenem tolerant.</title><p hwp:id="p-11">(A) Representative experiment demonstrating changes in OD<sub>600</sub> measurements following meropenem treatment in <italic toggle="yes">E. cloacae</italic> relative to <italic toggle="yes">E. coli</italic>. Error bars represent the average of 3 technical replicates +/− standard deviation. (B) Survival was calculated as CFU/mL from the experiment depicted in (A). The red line denotes the limit of detection. Phase images from the same experiment show cells before and after meropenem exposure to illustrate spheroplast formation in <italic toggle="yes">E. cloacae</italic> and lysis in <italic toggle="yes">E. coli</italic> (only cell debris is visible in phase image). Scale bars, 2 μm.</p></caption><graphic xlink:href="461800v2_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-12">When divalent cations are limiting, many Gram-negative pathogens induce outer membrane modifications (hyperacylation and/or increasing the positive charge of lipid A) to functionally substitute for divalent ionic bridges between lipopolysaccharide molecules (<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>). In <italic toggle="yes">E. cloacae</italic> (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>) and other Enterobacterales (<xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>), the PhoPQ TCS directly regulates expression of the <italic toggle="yes">arn</italic> operon, which synthesizes and transfers positively charged L-Ara4N moieties to lipid A, and <italic toggle="yes">pagP</italic>, which encodes an outer membrane acyltransferase (<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref>). To test whether the PhoPQ TCS contributes to meropenem tolerance, we measured spheroplast formation in Δ<italic toggle="yes">phoPQ</italic>. Strikingly, OD<sub>600</sub> declined sharply in Δ<italic toggle="yes">phoPQ</italic> relative to wild type, which could be fully complemented by ectopic expression of <italic toggle="yes">phoPQ</italic> (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2A</xref></bold>). The decline in spheroplast formation strongly correlated with a robust 10-fold decrease in Δ<italic toggle="yes">phoPQ</italic> viability (CFU/mL) relative to wild type after 24 hours of treatment (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig. 2B</xref></bold>). Step-wise titration of Ca<sup>2+</sup> and/or Mg<sup>2+</sup> markedly enhanced Δ<italic toggle="yes">phoPQ</italic> tolerance (<bold><xref ref-type="fig" rid="figS1" hwp:id="xref-fig-8-3" hwp:rel-id="F8">Fig. S1CD</xref></bold>), suggesting decreased tolerance (spheroplast formation) in Δ<italic toggle="yes">phoPQ</italic> is due to its inability to crosslink adjacent LPS molecules in the outer membrane. To corroborate the involvement of PhoPQ, we sought to either enhance or reduce its activity and measured the effect of such perturbations on tolerance. PhoQ is antagonized by the small periplasmic MgrB protein; <italic toggle="yes">mgrB</italic> overexpression is thus expected to result in suppression of PhoPQ induction (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>). Indeed, <italic toggle="yes">mgrB</italic> overexpression from a plasmid reduced spheroplast formation (proxied by OD<sub>600</sub> measurements) (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig. 2C</xref></bold>) in wild type, closely resembling the Δ<italic toggle="yes">phoPQ</italic> phenotype (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Fig. 2A</xref></bold>). Conversely, exposing a strain deleted in <italic toggle="yes">mgrB</italic> to meropenem resulted in an increase in OD<sub>600</sub> (<bold><xref ref-type="fig" rid="figS2" hwp:id="xref-fig-9-1" hwp:rel-id="F9">Fig. S2A</xref></bold>) that coincided with an approximately 1000-fold increased survival to meropenem relative to wild type (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Fig. 2B</xref></bold>). Modified lipid A structures in Δ<italic toggle="yes">mgrB</italic> were confirmed using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (<bold><xref ref-type="fig" rid="figS3" hwp:id="xref-fig-10-1" hwp:rel-id="F10">Fig. S3AB</xref></bold>). We also phenotypically validated our Δ<italic toggle="yes">mgrB</italic> mutant by assessing colistin MIC, which, as expected, was higher (≥128 μg/mL) than wild type (16 μg/mL). Collectively, our data suggest that the intensity of the PhoPQ response positively correlates with meropenem tolerance.</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5 xref-fig-2-6 xref-fig-2-7 xref-fig-2-8 xref-fig-2-9 xref-fig-2-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2:</label><caption hwp:id="caption-2"><title hwp:id="title-8">The PhoPQ system promotes meropenem tolerance in <italic toggle="yes">E. cloacae</italic>.</title><p hwp:id="p-13">(A) Spheroplast formation in response to meropenem treatment. Overnight cultures were diluted 10-fold into fresh LB medium containing 10 μg/mL meropenem and OD<sub>600</sub> was measured. (B) Fraction of population surviving after 24 hours of meropenem exposure from experiments as described in (A). (C) MgrB overexpression reduces tolerance. Cells were treated as described in (A), but with the addition of 0.2 % arabinose (inducer). pHERD; empty vector. (D) The <italic toggle="yes">arn</italic> operon is required for meropenem tolerance. Experiments were conducted as described in (A). Data in each graph represent the average of 3 replicates +/− standard deviation; additional biological replicates are shown in <xref ref-type="fig" rid="figS2" hwp:id="xref-fig-9-2" hwp:rel-id="F9">Fig. S2B</xref>. Statistical significance for survival fraction determined by one-way ANOVA of log transformed data, followed by Tukey’s correction for multiple comparisons (ns, not significant; ****, <italic toggle="yes">p</italic> ≤ 0.0001).</p></caption><graphic xlink:href="461800v2_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-14">To dissect individual contributions of PhoPQ-regulated genes to tolerance, we created mutants in the <italic toggle="yes">pagP</italic> and <italic toggle="yes">arn</italic> loci. While Δ<italic toggle="yes">pagP</italic> displayed spheroplast formation levels similar to wild type (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-6" hwp:rel-id="F2">Fig. 2D</xref></bold>), Δ<italic toggle="yes">arnT</italic> exhibited a drop in OD<sub>600</sub> reminiscent of Δ<italic toggle="yes">phoPQ</italic> (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-7" hwp:rel-id="F2">Fig. 2D</xref></bold>) and a concomitant 100-fold decrease in CFU/mL relative to wild type (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-8" hwp:rel-id="F2">Fig. 2B</xref></bold>). Notably, the survival defect was consistently more pronounced in Δ<italic toggle="yes">arnT</italic> vs. Δ<italic toggle="yes">phoPQ</italic> (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-9" hwp:rel-id="F2">Fig. 2B</xref></bold>), suggesting either that residual L-Ara4N modification is retained in the absence of PhoPQ through basal expression of <italic toggle="yes">arnT</italic>, or that <italic toggle="yes">phoPQ</italic> induction in the absence of <italic toggle="yes">arnT</italic> is detrimental for an unknown reason. However, we observed notable variation in the extent of <italic toggle="yes">arnT</italic> tolerance measured by OD<sub>600</sub>; in some experiments, tolerance was reduced slightly compared to WT (<bold><xref ref-type="fig" rid="figS2" hwp:id="xref-fig-9-3" hwp:rel-id="F9">Fig. S2B</xref></bold>), while in others, the mutant approached Δ<italic toggle="yes">phoPQ</italic> levels (<bold><xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-10" hwp:rel-id="F2">Fig. 2D</xref></bold>). Thus, L-Ara4N modification appears to be the principal, but not the only, PhoPQ-regulated tolerance factor. Variability might reflect stochastic variation in another tolerance factor that at least partially mitigates the effects of <italic toggle="yes">arnT</italic> deletion.</p></sec><sec id="s2b" hwp:id="sec-5"><title hwp:id="title-9">Meropenem induces <italic toggle="yes">arn</italic> transcription in a PhoPQ-dependent manner</title><p hwp:id="p-15">Expression of the <italic toggle="yes">arn</italic> operon in <italic toggle="yes">E. cloacae</italic> is directly regulated by phosphorylated PhoP (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref>). Because we observed that PhoPQ was necessary for <italic toggle="yes">arn-</italic>mediated tolerance, we asked whether meropenem induced <italic toggle="yes">arn</italic> transcription in a PhoPQ-dependent manner. To test this, <italic toggle="yes">E. cloacae</italic> cells were exposed to meropenem for 30 minutes, after which <italic toggle="yes">arnB</italic>, <italic toggle="yes">pagP</italic>, and <italic toggle="yes">phoP</italic> transcript levels were quantified (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig. 3A</xref></bold>). Relative expression was calculated using 16s rRNA as an internal control. <italic toggle="yes">phoP</italic>, which is autoregulated (<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>), showed 2.5-fold higher expression in meropenem-treated cells relative to untreated. Additionally, <italic toggle="yes">pagP</italic> expression was 5-fold higher, and <italic toggle="yes">arnB</italic> expression was 6-fold higher after meropenem treatment. These results support a model where PhoPQ signaling, as well as transcription of its regulon, is induced in response to meropenem treatment.</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3:</label><caption hwp:id="caption-3"><title hwp:id="title-10">Expression of <italic toggle="yes">arn</italic>B in response to meropenem treatment is dependent on PhoPQ.</title><p hwp:id="p-16">(A) Relative expression reverse-transcription quantitative PCR (qRT-PCR) of PhoPQ regulon transcripts after meropenem exposure. Each experiment was independently replicated three times (individual data points of the three experiments are reported here). (B) Strains carrying transcriptional P<sub><italic toggle="yes">arnB</italic></sub>:msGFP fusions were exposed to indicated conditions and analyzed on a C6 Accuri flow cytometer. Statistical difference between populations was determined with a one-way ANOVA followed by Tukey’s correction for multiple comparisons (ns, not significant; ****, <italic toggle="yes">p</italic> ≤ 0.0001).</p></caption><graphic xlink:href="461800v2_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-17">To corroborate the qRT PCR findings, we also constructed a fluorescent transcriptional reporter, fusing the <italic toggle="yes">arnB</italic> promoter (the first gene in the PhoPQ-regulated <italic toggle="yes">arn</italic> operon (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-3" hwp:rel-id="ref-22">22</xref>, <xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>)) with msfGFP, followed by fluorescence measurements upon exposure to meropenem (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig. 3B</xref></bold>). As a control, we first exposed cells to EDTA, which chelates divalent cations to destabilize the outer membrane and consequently activates PhoPQ (<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>). As expected, <italic toggle="yes">ParnB</italic>:msfGFP was induced by EDTA treatment in a <italic toggle="yes">phoPQ</italic>-dependent way (<bold><xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig. 3B</xref></bold>). Interestingly, meropenem treatment also robustly activated the <italic toggle="yes">ParnB</italic>:msfGFP reporter, where a significant 3-fold fluorescence increase was measured, comparable to EDTA treatment. In contrast, meropenem only slightly (but reproducibly) increased <italic toggle="yes">arnB</italic> expression in the Δ<italic toggle="yes">phoPQ</italic> mutant under the same conditions. Thus, <italic toggle="yes">arn</italic> transcription is induced by meropenem in a primarily PhoPQ-dependent manner.</p></sec><sec id="s2c" hwp:id="sec-6"><title hwp:id="title-11">Meropenem treatment promotes formation of L-Ara4N-modified lipid A species in a PhoPQ-dependent manner</title><p hwp:id="p-18">The LPS lipid A domain is modified with L-Ara4N in a PhoPQ-dependent manner when Mg<sup>2+</sup> is limiting (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-4" hwp:rel-id="ref-22">22</xref>), presumably to fortify the outer membrane during magnesium limitation stress. To determine if the <italic toggle="yes">E. cloacae</italic> lipid A structure is modified with L-Ara4N in response to meropenem treatment, we isolated lipid A from treated and untreated cultures. A distinct shift in lipid A structures was evident following 3 hours of meropenem treatment (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig. 4AB</xref></bold>), where increased ratios of L-Ara4N modified vs. unmodified forms were produced. Notably, the lipid A species that dominated before treatment (hexa-acylated, bis-phosphorylated, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> = 1825.25) decreased in abundance in favor of Arn- and PagP-modified lipid A. Doubly Arn/PagP-modified lipid A (<italic toggle="yes">m/z</italic> = 2114.14) was also produced following treatment. Notably, while L-Ara4N modification of lipid A was PhoPQ-dependent, PagP-dependent lipid A acylation was not (see below for discussion). Quantitative thin-layer chromatography supported the MS results and revealed a 12.21 (+/− 1.13)-fold increase in single-modified L-Ara4-N lipid A in a PhoPQ-dependent manner (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig. 4C</xref></bold>).</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Figure 4:</label><caption hwp:id="caption-4"><title hwp:id="title-12">Analysis of <italic toggle="yes">E. cloacae</italic> lipid A after meropenem treatment.</title><p hwp:id="p-19">(A) MALDI-TOF MS analysis of lipid A extracted from wild-type or Δ<italic toggle="yes">phoPQ E. cloacae</italic> strains. L-Ara4N modifications are illustrated in red, while C<sub>16:0</sub> additions are green. Numbered labels that are both red and green contain both modifications. Each experiment was independently replicated three times, and one representative data set was reported. (B) Predicted lipid A chemical structures in wild type and Δ<italic toggle="yes">phoPQ E. cloacae</italic>. (C) <sup>32</sup>P-radiolabelled lipid A was extracted from treated or untreated wild-type or Δ<italic toggle="yes">phoPQ E. cloacae</italic>. Lipids were separated based on hydrophobicity using thin-layer chromatography. Red circle denotes L-Ara4N modification, while the green line indicates C<sub>16:0</sub> addition.</p></caption><graphic xlink:href="461800v2_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-20"><italic toggle="yes">E. cloacae</italic> encodes a principal putative PagP acyltransferase that we denoted as PagP1 (Ecl_03072) and PagP2 (Ecl_04468), a second apparent paralog. Lipid A extracted from Δ<italic toggle="yes">pagP1</italic> lacked the acyl chain induced upon meropenem treatment (<bold><xref ref-type="fig" rid="figS4" hwp:id="xref-fig-11-1" hwp:rel-id="F11">Fig. S4A</xref></bold>), suggesting that PagP1 removes palmitate (C<sub>16:0</sub>) from surface-exposed glycerophospholipids and transfers it to lipid A, as previously shown (<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>, <xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>), and demonstrating that PagP2 does not contribute to hyperacylation under these conditions. We also confirmed that meropenem-induced L-Ara4N modification was dependent on the <italic toggle="yes">arn</italic> operon (<bold><xref ref-type="fig" rid="figS4" hwp:id="xref-fig-11-2" hwp:rel-id="F11">Fig. S4B</xref></bold>). Furthermore, MS analysis of Δ<italic toggle="yes">phoPQ</italic> Δ<italic toggle="yes">pagP1</italic> (<bold><xref ref-type="fig" rid="figS4" hwp:id="xref-fig-11-3" hwp:rel-id="F11">Fig. S4C</xref></bold>) and Δ<italic toggle="yes">arn</italic> Δ<italic toggle="yes">pagP1</italic> (<bold><xref ref-type="fig" rid="figS4" hwp:id="xref-fig-11-4" hwp:rel-id="F11">Fig. S4D</xref></bold>) lipid A revealed that the mutants produced lipid A structures lacking all modifications following meropenem treatment, confirming that PagP1 and the <italic toggle="yes">arn</italic> operon products coordinate <italic toggle="yes">E. cloacae</italic> lipid A modifications in response to meropenem treatment. Interestingly, meropenem-induced hyperacylation was absent in Δ<italic toggle="yes">mgrB</italic> cells (<bold><xref ref-type="fig" rid="figS3" hwp:id="xref-fig-10-2" hwp:rel-id="F10">Fig. S3A</xref></bold>). We propose that meropenem-induced hyperacylation might actually be reflective of enhanced outer membrane glycerophospholipid bilayer accumulation in spheroplasts, a condition known for its likely ability to post-translationally activate PagP1 enzymatic activity (<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref>, <xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>). This model is also consistent with our observation that while PagP1 is under genetic control of PhoPQ (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-5" hwp:rel-id="ref-22">22</xref>), meropenem-induced hyperacylation is independent of PhoPQ (<bold><xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig. 4AC</xref></bold>). The absence of PagP1-dependent modification in Δ<italic toggle="yes">mgrB</italic> might indicate increased outer membrane strength (and concomitant reduction in glycerophospholipid in the outer leaflet of the outer membrane) in this background.</p><p hwp:id="p-21">Based on the structural studies and our genetic evidence, we suggest PhoPQ-dependent tolerance is primarily mediated via L-Ara4N addition to lipid A. Presumably, L-Ara4N lipid A modification increases the structural integrity of the outer membrane through stabilization of lateral lipopolysaccharide interactions, which protects spheroplasts from internal turgor.</p></sec><sec id="s2d" hwp:id="sec-7"><title hwp:id="title-13">Colistin exposure primes <italic toggle="yes">E. cloacae</italic> for meropenem tolerance</title><p hwp:id="p-22">Cationic antimicrobial peptides (CAMPs) are known inducers of the PhoPQ TCS (<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>). Since our data above suggest that PhoPQ induction promotes tolerance, we hypothesized that pre-exposure to the CAMP colistin “primes” <italic toggle="yes">E. cloacae</italic> for tolerance to meropenem, either by inducing PhoPQ or by selecting for cells that have a higher baseline level of PhoPQ induction. To test this, we measured the extent to which <italic toggle="yes">E. cloacae</italic> was killed by meropenem with and without prior growth in colistin-containing media. Interestingly, after pre-exposure to colistin, the fraction of cells surviving meropenem treatment was approximately 10-fold greater (<bold><xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig. 5</xref></bold>). This suggests that CAMPs have the potential to induce tolerance to other antibiotics, but that the temporal conditions of treatment may determine the extent to which this effect is significant.</p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Figure 5:</label><caption hwp:id="caption-5"><title hwp:id="title-14">Colistin primes <italic toggle="yes">E. cloacae</italic> for meropenem tolerance.</title><p hwp:id="p-23">Overnight cultures were grown in LB +/− 20 μg/mL colistin, then diluted 10-fold into LB +/− 20 μg/mL colistin. Colistin pretreatment value represents total time exposed to colistin before exposure to 10 μg/mL meropenem. Cultures were then treated like other meropenem killing experiments (see methods). Survival fraction was calculated by dividing CFU/mL at 3h meropenem exposure by CFU/mL prior to meropenem exposure. Each bar represents the mean of 9 biological replicates, error bars represent standard deviation. Statistical significance determined by one-way ANOVA of log transformed data, followed by Tukey’s correction for multiple comparisons (ns, not significant; *, <italic toggle="yes">p</italic> ≤ 0.05; **, <italic toggle="yes">p</italic> ≤ 0.01).</p></caption><graphic xlink:href="461800v2_fig5" position="float" orientation="portrait" hwp:id="graphic-5"/></fig></sec><sec id="s2e" hwp:id="sec-8"><title hwp:id="title-15">Outer membrane modifications are conserved β-lactam tolerance determinants in other Enterobacterales</title><p hwp:id="p-24">We next sought to establish whether outer membrane modifications might promote tolerance in other Enterobacterales. We first turned to <italic toggle="yes">Klebsiella pneumoniae</italic> and used transposon insertion mutants in <italic toggle="yes">phoP</italic> and <italic toggle="yes">phoQ</italic> from the Manoil laboratory’s arrayed transposon mutant library (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>) in killing experiments. After 6 hours of meropenem exposure, both the <italic toggle="yes">phoQ::Tn</italic> and <italic toggle="yes">phoP::Tn</italic> mutants exhibited 20- to 50-fold lower survival compared to the wild-type (<bold><xref ref-type="fig" rid="fig6" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Fig. 6A</xref></bold>). We next used an <italic toggle="yes">E. coli</italic> K12 variant (WD101) engineered to constitutively upregulate the PmrAB two-component system (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>) (which regulates L-Ara4N modification of lipid A in <italic toggle="yes">E. coli</italic>) to test the hypothesis that outer membrane modifications increase tolerance in <italic toggle="yes">E. coli</italic> (<bold><xref ref-type="fig" rid="fig6" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Fig. 6B</xref></bold>). WD101 exhibited a dramatic, 10,000-fold increase in survival after 24 hours of meropenem exposure compared to the wild-type parental strain, further supporting a role for outer membrane modifications in meropenem tolerance.</p><fig id="fig6" position="float" orientation="portrait" fig-type="figure" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Figure 6:</label><caption hwp:id="caption-6"><title hwp:id="title-16">A conserved mechanism for meropenem tolerance in Enterobacterales.</title><p hwp:id="p-25">(A) <italic toggle="yes">Klebsiella pneumoniae</italic> KPNIH1 and its <italic toggle="yes">phoP</italic>::Tn and <italic toggle="yes">phoQ::Tn</italic> derivatives were diluted 10-fold into LB medium containing 10 μg/mL meropenem. Survival fraction is the CFU/mL after 6 hours of meropenem treatment divided by CFU/mL before treatment. Data represent averages of 6 biological replicates +/− standard error (B) <italic toggle="yes">E. coli</italic> strain W3110 (WT) or strain WD101, which has a constitutively active chromosomal copy of <italic toggle="yes">pmrA</italic> (<italic toggle="yes">pmrA<sup>C</sup></italic>), were cultured in N-minimal medium and treated with or without meropenem. Cultures were incubated statically at 37°C. CFU were enumerated at 0, 3, 6, 12 and 24 hours. Error bars indicate standard deviation. Each experiment was independently replicated three times in triplicate, and one representative data set was reported.</p></caption><graphic xlink:href="461800v2_fig6" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec><sec id="s2f" hwp:id="sec-9"><title hwp:id="title-17">A small molecule inhibitor of PhoQ synergizes with meropenem and colistin in vitro</title><p hwp:id="p-26">Tolerance is likely an under-appreciated contributor to antibiotic treatment failure. Antibiotic adjuvants that promote killing of tolerant cells thus have the potential to find a prominent place in our antibiotic armamentarium. Since histidine kinases like PhoQ are in principle targetable by small molecules, we tested whether his-kinase inhibitors synergized with meropenem. To this end, we turned to a previously developed suite of small molecules with potent histidine kinase inhibitory activity (<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>) and tested them in combination with meropenem. The anti-Amyotrophic Lateral Sclerosis (ALS) drug Riluzole, as well as its derivative Rilu-2, exhibited potent, concentration-dependent synergy in lysing tolerant <italic toggle="yes">E. cloacae</italic> cells <italic toggle="yes">in vitro</italic> (<bold><xref ref-type="fig" rid="fig7" hwp:id="xref-fig-7-1" hwp:rel-id="F7">Fig. 7A</xref>, <xref ref-type="fig" rid="figS5" hwp:id="xref-fig-12-1" hwp:rel-id="F12">Fig. S5A</xref></bold>). We also verified that Rilu-2 inhibited the formation of PhoPQ-dependent lipid A modifications using MALDI-TOF MS (<bold><xref ref-type="fig" rid="fig7" hwp:id="xref-fig-7-2" hwp:rel-id="F7">Fig. 7B</xref></bold>). Since the PhoPQ system is primarily recognized for its contribution to CAMP resistance in many Enterobacterales, we next tested the Rilu compounds’ ability to synergize with colistin. As expected, Rilu-2 and Riluzole indeed potentiated colistin-mediated killing (<bold><xref ref-type="fig" rid="figS5" hwp:id="xref-fig-12-2" hwp:rel-id="F12">Fig. S5B</xref></bold>), lending additional support to a PhoQ-inhibitory role of these compounds and also confirming previous results in <italic toggle="yes">Salmonella</italic> (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>). Importantly, Riluzole is an FDA-approved treatment for ALS and could thus readily serve as an adjuvant against both meropenem-tolerant and colistin-resistant Enterobacterales.</p><fig id="fig7" position="float" orientation="portrait" fig-type="figure" hwp:id="F7" hwp:rev-id="xref-fig-7-1 xref-fig-7-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIG7</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">fig7</object-id><label>Figure 7:</label><caption hwp:id="caption-7"><title hwp:id="title-18">Rilu compounds synergize with meropenem to expedite <italic toggle="yes">E. cloacae</italic> killing.</title><p hwp:id="p-27">(A) Rilu compounds potentiate meropenem-induced lysis against <italic toggle="yes">E. cloacae</italic>. Overnight cultures were diluted 10-fold into fresh growth medium containing meropenem (10 μg/mL) and increasing concentrations of Riluzole or its derivative Rilu-2. Data represent the average of 3 technical replicates +/− standard deviation. (B) MALDI-MS analysis of lipid A isolated from untreated wild-type <italic toggle="yes">E. cloacae</italic>, cells treated with RILU-2 or Δ<italic toggle="yes">phoPQ. m/z</italic> corresponding with L-Ara4N modifications are illustrated in red. Relevant lipid A chemical structures are shown. Each experiment was independently replicated three times, and one representative data set is reported.</p></caption><graphic xlink:href="461800v2_fig7" position="float" orientation="portrait" hwp:id="graphic-7"/></fig></sec></sec><sec id="s3" hwp:id="sec-10"><title hwp:id="title-19">Discussion</title><p hwp:id="p-28">While much work has been done in Enterobacterales to elucidate mechanisms of antibiotic resistance and persistence, the genetic and molecular determinants of tolerance, and especially spheroplast formation, have remained poorly understood. In contrast to resistance (continued growth) and persistence (dormancy), carbapenem-tolerant populations are initially susceptible to treatment (i.e., lose their cell wall). This phenotype is reminiscent of so-called “L-forms” (<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref>), with the notable difference that spheroplasts do not replicate in this state, while L-forms do. This is likely a consequence of L-forms being able to “escape” the outer membrane to then proliferate through stochastic membrane blebs (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>).</p><p hwp:id="p-29">The remarkable ability of spheroplasts to survive without their PG layer lends support to the recent realization that the outer membrane has load-bearing capabilities (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>) and prompted us to interrogate the molecular mechanism of outer membrane stabilization during antibiotic exposure. Our data suggest that L-Ara4N addition to lipid A is a key factor in spheroplast integrity. We propose that modifying lipid A molecules with a positive charge might increase outer membrane stability due to the enhancement of electrostatic interactions between adjacent LPS molecules on the surface-exposed face of the outer membrane. Of note, the L-Ara4N modification has been previously implicated in resistance to CAMPs, such as colistin (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-6" hwp:rel-id="ref-22">22</xref>). In this context, it is worrisome that colistin therapy can select for <italic toggle="yes">mgrB</italic> mutations (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>–<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref>), which we demonstrate here also confers high meropenem tolerance in addition to colistin resistance. Thus, treatment with antimicrobial peptide analogs (and, although we did not test this directly, potentially innate AMPs) can select for bacteria that are stably tolerant to subsequent therapy with a β-lactam. Our data also suggest that colistin (and, by extension, potentially AMPs of the innate immune system) can induce transient β-lactam tolerance, likely through induction of the PhoPQ system and perhaps other protective stress responses. However, the relationship between PhoPQ induction and tolerance is not absolute; a significant proportion of both colistin-pretreated and <italic toggle="yes">mgrB-</italic>deleted cells still lyse in the presence of meropenem. We speculate that β-lactam tolerance and colistin resistance, while relying on the same basic outer membrane modification, may each require a specific fraction of LPS molecules to be modified. Thus, within a sample, there may be a limited subset of cells exhibiting the correct amount of modification to enable both colistin resistance and meropenem tolerance (or even just optimal meropenem tolerance). This would explain why we observe only partial overlap between these two phenomena.</p><p hwp:id="p-30">In summary, this work demonstrates a novel genetic determinant of carbapenem tolerance in clinically relevant Enterobacterales. Despite being a well-known regulator of polymyxin resistance, the PhoPQ two-component system was not previously known to respond or mediate tolerance to carbapenem treatment. As tolerance (and spheroplast formation in particular) is a possible culprit for antibiotic treatment failure (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-2" hwp:rel-id="ref-2">2</xref>, <xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>), our results suggest a potential for combination therapies with histidine kinase inhibitors to increase the efficacy of carbapenems.</p></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-20">Acknowledgements</title><p hwp:id="p-31">Research on tolerance in the Dörr lab is supported by National Institutes of Health (NIH/NIAID) grant R01AI143704. Research in the Boll lab is supported by National Institutes of Health (NIH/NIGMS) grant GM143053. Histidine kinase inhibitor research in the Carlson lab supported by National Institutes of Health (NIH/NIGMS) grant GM134538-01A1 and the UMN Office of Academic Clinical Affairs.</p></ack><sec id="s4" hwp:id="sec-11"><title hwp:id="title-21">Materials and Methods</title><sec id="s4a" hwp:id="sec-12"><title hwp:id="title-22">Bacterial strains and growth</title><p hwp:id="p-32">All strains/plasmids and primers used in this study are listed in <bold>Table S1 and S2</bold>. All strains were initially grown from freezer stocks on solid agar at 37°C. Isolated colonies were used to inoculate Luria-Bertani (LB), Brain heart infusion (BHI) or N-minimal medium at 37°C. Where required, kanamycin was used at 50 μg/mL, meropenem and colistin were used at 10 μg/mL, unless noted otherwise.</p></sec><sec id="s4b" hwp:id="sec-13"><title hwp:id="title-23">Meropenem killing experiments</title><p hwp:id="p-33">Unless noted otherwise, killing experiments were conducted in 100-well honeycomb plates in a Bioscreen C growth curve analyzer (Growth Curves USA, Piscataway NJ). Overnight cultures were diluted 10-fold into fresh LB medium containing meropenem (10 μg/mL, 300x MIC) and transferred to honeycomb plates (200 μL volume/culture). OD<sub>600</sub> was measured by plate reader; at indicated timepoints, the experiment was paused and an aliquot was removed for CFU/mL determination or microscopy. Rilu compounds were dissolved in DMSO as 50 mM (Rilu-2) or 500 mM (Riluzole) stocks and added directly to the LB medium containing meropenem at the indicated concentrations.</p></sec><sec id="s4c" hwp:id="sec-14"><title hwp:id="title-24">Colistin MIC experiment</title><p hwp:id="p-34">Cultures were grown overnight at 37°C shaking, then diluted 1000-fold into fresh LB. Subcultures were grown for 1 hour at 37°C shaking before being diluted 1000-fold again into fresh LB to create a “seed culture”. 100 μL of seed culture was subsequently diluted 2-fold into a 96-well plate containing colistin concentrations ranging 0.25 – 128 μg/mL. Reported values are medians of 4 technical replicates.</p></sec><sec id="s4d" hwp:id="sec-15"><title hwp:id="title-25">qRT-PCR</title><p hwp:id="p-35">Relative-abundance quantitative PCR (qPCR) was performed as previously described (<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref>, <xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref>). In brief, the Sybr Fast One-Step qRT-PCR kit (Kapa Biosystems) was used with 16S rDNA as the internal reference. The PCR reaction was performed with Applied Systems RNA-Ct one-step system. Relative expression levels were calculated using the ΔΔCt method (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref>), with normalization of gene targets to16S rDNA signals.</p></sec><sec id="s4e" hwp:id="sec-16"><title hwp:id="title-26">Flow cytometry GFP measurements</title><p hwp:id="p-36">Cultures of strains harboring transcriptional <italic toggle="yes">P<sub>arnB</sub></italic>:msfGFP fusions were grown overnight in LB supplemented with 10 mM MgSO<sub>4</sub>. Overnight cultures were then washed 2x in fresh LB before 10-fold dilution into fresh LB medium containing MgSO<sub>4</sub> (10 mM),</p><p hwp:id="p-37">Ethylenediaminetetraacetic acid (1 mM), or meropenem (10 μg/mL). Cultures were incubated statically for 3 hours at 37°C. Then, 500 μL of culture was harvested and run through a C6 Accuri flow cytometer (BD Biosciences) until 100,000 events (cells) had been analyzed. Mean green fluorescence as measured by the FL1-A channel was used as a readout for GFP.</p></sec><sec id="s4f" hwp:id="sec-17"><title hwp:id="title-27">Mutant construction</title><p hwp:id="p-38"><italic toggle="yes">E. cloacae</italic> subsp. <italic toggle="yes">cloacae</italic> 13047 mutant strains (<italic toggle="yes">phoPQ</italic>, <italic toggle="yes">arn</italic> and <italic toggle="yes">arnT</italic>) were constructed as previously described using recombineering with the plasmid pKOBEG (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-7" hwp:rel-id="ref-22">22</xref>, <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref>). Briefly, linear PCR products were amplified from pKD3 and transformed into <italic toggle="yes">E. cloacae</italic> ATCC 13047/pKOBEG strain by electroporation and plated on chloramphenicol selective media. Selected clones were transformed with pCP20 to cure the antibiotic resistance cassette. All mutants were verified by PCR.</p><p hwp:id="p-39"><italic toggle="yes">pagP1</italic> was deleted using the Wanner method as described previously (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-8" hwp:rel-id="ref-22">22</xref>). Briefly, the chl resistance cassette was amplified from pKD3 using primers TDP1532/TDP1533, which contain 75 bp flanking homology overhangs. The resulting PCR product was electroporated into <italic toggle="yes">E. cloacae</italic> ATCC13047 expressing lambda red recombinase from pACBSR-hyg (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref>) (a hygromycin-resistant derivative of pKD46 (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref>)). Mutants were selected on chloramphenicol (100 μg/mL) and verified by PCR.</p><p hwp:id="p-40">Other mutants were constructed using either lambda red recombinase (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-2" hwp:rel-id="ref-49">49</xref>) or the suicide vector pTox (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref>). The <italic toggle="yes">mgrB</italic> gene was deleted using the suicide plasmid pTox5 as described in (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-2" hwp:rel-id="ref-50">50</xref>). ~700 bp upstream and downstream flanking homology regions were amplified from ATCC13047 using primers TDP1767/68 and TDP1769/70, and cloned into pTox5 (digested with EcoRV) using isothermal assembly (<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">51</xref>). Successful pTox5Δ<italic toggle="yes">mgrB</italic> were conjugated into ATCC13047 using the <italic toggle="yes">E. coli</italic> donor strain MFD lambda <italic toggle="yes">pir</italic>; successful recombinants were selected on plates containing 100 μg/mL chloramphenicol. Upon single colony purification, colonies were directly streaked out on an M9 minimal medium plate containing 0.2 % casamino acids and 1 % rhamnose, followed by incubation at 30 °C for 24 – 36 hours. Mutants were tested using primers TDP1771/72.</p></sec><sec id="s4g" hwp:id="sec-18"><title hwp:id="title-28">Lipid A isolation and mass spectrometry</title><p hwp:id="p-41">Isolation of lipid A for analysis was performed as previously described (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">52</xref>) with slight modifications. To analyze lipid A after meropenem treatment, overnight cultures grown in BHI broth were diluted 1:10 in pre-warmed media with or without meropenem statically for 3 h. To assess Rilu-dependent modification of lipid A, 12.5 mL of <italic toggle="yes">E. cloacae</italic> was grown to OD<sub>600</sub> 1.0. Rilu-2 was used at a final concentration of 200 μM. Bacteria were harvested and lipid A extraction was carried out by mild-acid hydrolysis as previously described (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">53</xref>). For mass spectrometry (MS), data were collected on a MALDI-TOF (Axima Confidence, Shimadzu) mass spectrometer in the negative mode, as previously done (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-9" hwp:rel-id="ref-22">22</xref>).</p><p hwp:id="p-42">For quantification of lipid A, cultures were grown with 2.5 μCi/mL of <sup>32</sup>P orthophosphoric acid (<sup>32</sup>P) (Perkin Elmer) and lipid A was extracted. Thin layer chromotagraphy was done in a pyridine, chloroform, 88% formic acid, aqueous (50:50:16:5 v/v) tank for 3 hours. Plates were exposed to a phosphor screen, imaged, and densitometry was used to calculate the percentage of each lipid species. Reported densitometry was calculated using 2 replicates +/− standard deviation.</p></sec></sec><sec hwp:id="sec-19"><title hwp:id="title-29">Figure Legends</title><fig id="figS1" position="float" orientation="portrait" fig-type="figure" hwp:id="F8" hwp:rev-id="xref-fig-8-1 xref-fig-8-2 xref-fig-8-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIGS1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">figS1</object-id><label>Figure S1:</label><caption hwp:id="caption-8"><title hwp:id="title-30">Addition of divalent cations prevents spheroplast lysis.</title><p hwp:id="p-43">Wild type (WT) (A-B) or its Δ<italic toggle="yes">phoPQ</italic> derivative (C-D) were treated as described in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Fig. 1A</xref> with addition of the indicated concentrations of (A,C) MgSO<sub>4</sub> (Mg<sup>2+</sup>) or (B,D) CaCl<sub>2</sub> (Ca<sup>2+</sup>). Data represent the average of 3 replicates +/− standard deviation.</p></caption><graphic xlink:href="461800v2_figS1" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><fig id="figS2" position="float" orientation="portrait" fig-type="figure" hwp:id="F9" hwp:rev-id="xref-fig-9-1 xref-fig-9-2 xref-fig-9-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIGS2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F9</object-id><object-id pub-id-type="publisher-id">figS2</object-id><label>Figure S2:</label><caption hwp:id="caption-9"><title hwp:id="title-31">Independent biological replicates of experiments shown in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig. 1</xref>.</title><p hwp:id="p-44">(A) An <italic toggle="yes">mgrB</italic> mutation promotes a moderate increase in mass increase during meropenem exposure. (B) Experiments were conducted as described in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Fig. 1A</xref> legend; each graph represents experiments conducted on a different day. In addition, data in each graph represent the average of 3 biological replicates +/− standard deviation.</p></caption><graphic xlink:href="461800v2_figS2" position="float" orientation="portrait" hwp:id="graphic-9"/></fig><fig id="figS3" position="float" orientation="portrait" fig-type="figure" hwp:id="F10" hwp:rev-id="xref-fig-10-1 xref-fig-10-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIGS3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F10</object-id><object-id pub-id-type="publisher-id">figS3</object-id><label>Figure S3:</label><caption hwp:id="caption-10"><title hwp:id="title-32">Analysis of lipid A from Δ<italic toggle="yes">mgrB</italic>.</title><p hwp:id="p-45">(A) MALDI-MS analysis of lipid A isolated from <italic toggle="yes">E. cloacae</italic> Δ<italic toggle="yes">mgrB</italic>. <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> corresponding with L-Ara4N modifications are illustrated in red. Each experiment was independently replicated three times, and one representative data set was reported. (B) Relevant lipid A chemical structures are shown.</p></caption><graphic xlink:href="461800v2_figS3" position="float" orientation="portrait" hwp:id="graphic-10"/></fig><fig id="figS4" position="float" orientation="portrait" fig-type="figure" hwp:id="F11" hwp:rev-id="xref-fig-11-1 xref-fig-11-2 xref-fig-11-3 xref-fig-11-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIGS4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F11</object-id><object-id pub-id-type="publisher-id">figS4</object-id><label>Figure S4:</label><caption hwp:id="caption-11"><title hwp:id="title-33">Analysis of lipid A from <italic toggle="yes">E. cloacae</italic> mutants.</title><p hwp:id="p-46">(A) MALDI-MS analysis of lipid A isolated from Δ<italic toggle="yes">pagP1</italic>, (B) Δ<italic toggle="yes">arn</italic>, (C) Δ<italic toggle="yes">phoPQ</italic> Δ<italic toggle="yes">pagP1 and</italic> (D) Δ<italic toggle="yes">arn</italic> Δ<italic toggle="yes">pagP1</italic>. <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> corresponding with L-Ara4N modifications are illustrated in red, while structures with altered acyl chain patterns are illustrated in green. Each experiment was independently replicated three times, and one representative data set was reported.</p></caption><graphic xlink:href="461800v2_figS4" position="float" orientation="portrait" hwp:id="graphic-11"/></fig><fig id="figS5" position="float" orientation="portrait" fig-type="figure" hwp:id="F12" hwp:rev-id="xref-fig-12-1 xref-fig-12-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.25.461800v2/FIGS5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F12</object-id><object-id pub-id-type="publisher-id">figS5</object-id><label>Figure S5:</label><caption hwp:id="caption-12"><title hwp:id="title-34">Rilu synergizes with colistin to enhance killing.</title><p hwp:id="p-47">(A) Rilu compounds do not cause lysis, but (B) potentiate colistin mediate killing. Experiments were conducted as described in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig. 1A</xref> legend. Data represent the average of 3 replicates +/− standard deviation.</p></caption><graphic xlink:href="461800v2_figS5" position="float" orientation="portrait" hwp:id="graphic-12"/></fig></sec><ref-list hwp:id="ref-list-1"><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Brauner A."><given-names>A.</given-names> <surname>Brauner</surname></string-name>, <string-name name-style="western" hwp:sortable="Fridman O."><given-names>O.</given-names> <surname>Fridman</surname></string-name>, <string-name name-style="western" hwp:sortable="Gefen O."><given-names>O.</given-names> <surname>Gefen</surname></string-name>, <string-name name-style="western" hwp:sortable="Balaban N. Q."><given-names>N. Q.</given-names> <surname>Balaban</surname></string-name>, <article-title hwp:id="article-title-2">Distinguishing between resistance, tolerance and persistence to antibiotic treatment</article-title>. <source hwp:id="source-1">Nat Rev Microbiol</source> <volume>14</volume>, <fpage>320</fpage>–<lpage>330</lpage> (<year>2016</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1 xref-ref-2-2"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Dorr T."><given-names>T.</given-names> <surname>Dorr</surname></string-name>, <article-title hwp:id="article-title-3">Understanding tolerance to cell wall-active antibiotics</article-title>. <source hwp:id="source-2">Ann N Y Acad Sci</source> <volume>1496</volume>, <fpage>35</fpage>–<lpage>58</lpage> (<year>2021</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Westblade L. F."><given-names>L. F.</given-names> <surname>Westblade</surname></string-name>, <string-name name-style="western" hwp:sortable="Errington J."><given-names>J.</given-names> <surname>Errington</surname></string-name>, <string-name name-style="western" hwp:sortable="Dorr T."><given-names>T.</given-names> <surname>Dorr</surname></string-name>, <article-title hwp:id="article-title-4">Antibiotic tolerance</article-title>. <source hwp:id="source-3">PLoS Pathog</source> <volume>16</volume>, <fpage>e1008892</fpage> (<year>2020</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Levin-Reisman I."><given-names>I.</given-names> <surname>Levin-Reisman</surname></string-name>, <string-name name-style="western" hwp:sortable="Brauner A."><given-names>A.</given-names> <surname>Brauner</surname></string-name>, <string-name name-style="western" hwp:sortable="Ronin I."><given-names>I.</given-names> <surname>Ronin</surname></string-name>, <string-name name-style="western" hwp:sortable="Balaban N. Q."><given-names>N. Q.</given-names> <surname>Balaban</surname></string-name>, <article-title hwp:id="article-title-5">Epistasis between antibiotic tolerance, persistence, and resistance mutations</article-title>. <source hwp:id="source-4">Proc Natl Acad Sci U S A</source> <volume>116</volume>, <fpage>14734</fpage>–<lpage>14739</lpage> (<year>2019</year>).</citation></ref><ref id="c5" hwp:id="ref-5"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Levin-Reisman I."><given-names>I.</given-names> <surname>Levin-Reisman</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-6">Antibiotic tolerance facilitates the evolution of resistance</article-title>. <source hwp:id="source-5">Science</source> <volume>355</volume>, <fpage>826</fpage>–<lpage>830</lpage> (<year>2017</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Liu J."><given-names>J.</given-names> <surname>Liu</surname></string-name>, <string-name name-style="western" hwp:sortable="Gefen O."><given-names>O.</given-names> <surname>Gefen</surname></string-name>, <string-name name-style="western" hwp:sortable="Ronin I."><given-names>I.</given-names> <surname>Ronin</surname></string-name>, <string-name name-style="western" hwp:sortable="Bar-Meir M."><given-names>M.</given-names> <surname>Bar-Meir</surname></string-name>, <string-name name-style="western" hwp:sortable="Balaban N. Q."><given-names>N. Q.</given-names> <surname>Balaban</surname></string-name>, <article-title hwp:id="article-title-7">Effect of tolerance on the evolution of antibiotic resistance under drug combinations</article-title>. <source hwp:id="source-6">Science</source> <volume>367</volume>, <fpage>200</fpage>–<lpage>204</lpage> (<year>2020</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Dorr T."><given-names>T.</given-names> <surname>Dorr</surname></string-name>, <string-name name-style="western" hwp:sortable="Davis B. M."><given-names>B. M.</given-names> <surname>Davis</surname></string-name>, <string-name name-style="western" hwp:sortable="Waldor M. K."><given-names>M. K.</given-names> <surname>Waldor</surname></string-name>, <article-title hwp:id="article-title-8">Endopeptidase-mediated beta lactam tolerance</article-title>. <source hwp:id="source-7">PLoS Pathog</source> <volume>11</volume>, <fpage>e1004850</fpage> (<year>2015</year>).</citation></ref><ref id="c8" hwp:id="ref-8"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Monahan L. G."><given-names>L. G.</given-names> <surname>Monahan</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-9">Rapid conversion of Pseudomonas aeruginosa to a spherical cell morphotype facilitates tolerance to carbapenems and penicillins but increases susceptibility to antimicrobial peptides</article-title>. <source hwp:id="source-8">Antimicrob Agents Chemother</source> <volume>58</volume>, <fpage>1956</fpage>–<lpage>1962</lpage> (<year>2014</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1 xref-ref-9-2 xref-ref-9-3 xref-ref-9-4"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.9" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Cross T."><given-names>T.</given-names> <surname>Cross</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-10">Spheroplast-Mediated Carbapenem Tolerance in Gram-Negative Pathogens</article-title>. <source hwp:id="source-9">Antimicrob Agents Chemother</source> <volume>63</volume> (<year>2019</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.10" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Errington J."><given-names>J.</given-names> <surname>Errington</surname></string-name>, <string-name name-style="western" hwp:sortable="Mickiewicz K."><given-names>K.</given-names> <surname>Mickiewicz</surname></string-name>, <string-name name-style="western" hwp:sortable="Kawai Y."><given-names>Y.</given-names> <surname>Kawai</surname></string-name>, <string-name name-style="western" hwp:sortable="Wu L. J."><given-names>L. J.</given-names> <surname>Wu</surname></string-name>, <article-title hwp:id="article-title-11">L-form bacteria, chronic diseases and the origins of life</article-title>. <source hwp:id="source-10">Philos Trans R Soc Lond B Biol Sci</source> <volume>371</volume> (<year>2016</year>).</citation></ref><ref id="c11" hwp:id="ref-11"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.11" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Mercier R."><given-names>R.</given-names> <surname>Mercier</surname></string-name>, <string-name name-style="western" hwp:sortable="Kawai Y."><given-names>Y.</given-names> <surname>Kawai</surname></string-name>, <string-name name-style="western" hwp:sortable="Errington J."><given-names>J.</given-names> <surname>Errington</surname></string-name>, <article-title hwp:id="article-title-12">General principles for the formation and proliferation of a wall-free (L-form) state in bacteria</article-title>. <source hwp:id="source-11">Elife</source> <volume>3</volume> (<year>2014</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Errington J."><given-names>J.</given-names> <surname>Errington</surname></string-name>, <article-title hwp:id="article-title-13">Cell wall-deficient, L-form bacteria in the 21st century: a personal perspective</article-title>. <source hwp:id="source-12">Biochem Soc Trans</source> <volume>45</volume>, <fpage>287</fpage>–<lpage>295</lpage> (<year>2017</year>).</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Shin J. H."><given-names>J. H.</given-names> <surname>Shin</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-14">A multifaceted cellular damage repair and prevention pathway promotes high-level tolerance to beta-lactam antibiotics</article-title>. <source hwp:id="source-13">EMBO Rep</source> <volume>22</volume>, <fpage>e51790</fpage> (<year>2021</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Dorr T."><given-names>T.</given-names> <surname>Dorr</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-15">A cell wall damage response mediated by a sensor kinase/response regulator pair enables beta-lactam tolerance</article-title>. <source hwp:id="source-14">Proc Natl Acad Sci U S A</source> <volume>113</volume>, <fpage>404</fpage>–<lpage>409</lpage> (<year>2016</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Paterson D. L."><given-names>D. L.</given-names> <surname>Paterson</surname></string-name>, <article-title hwp:id="article-title-16">Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)</article-title>. <source hwp:id="source-15">Clin Microbiol Infect</source> <volume>6</volume>, <fpage>460</fpage>–<lpage>463</lpage> (<year>2000</year>).</citation></ref><ref id="c16" hwp:id="ref-16"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Torres J. A."><given-names>J. A.</given-names> <surname>Torres</surname></string-name>, <string-name name-style="western" hwp:sortable="Villegas M. V."><given-names>M. V.</given-names> <surname>Villegas</surname></string-name>, <string-name name-style="western" hwp:sortable="Quinn J. P."><given-names>J. P.</given-names> <surname>Quinn</surname></string-name>, <article-title hwp:id="article-title-17">Current concepts in antibiotic-resistant Gram-negative bacteria</article-title>. <source hwp:id="source-16">Expert Review of Anti-infective Therapy</source> <volume>5</volume>, <fpage>833</fpage>–<lpage>843</lpage> (<year>2007</year>).</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Paterson D. L."><given-names>D. L.</given-names> <surname>Paterson</surname></string-name>, <string-name name-style="western" hwp:sortable="Bonomo R. A."><given-names>R. A.</given-names> <surname>Bonomo</surname></string-name>, <article-title hwp:id="article-title-18">Extended-spectrum beta-lactamases: a clinical update</article-title>. <source hwp:id="source-17">Clin Microbiol Rev</source> <volume>18</volume>, <fpage>657</fpage>–<lpage>686</lpage> (<year>2005</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Groisman E. A."><given-names>E. A.</given-names> <surname>Groisman</surname></string-name>, <string-name name-style="western" hwp:sortable="Duprey A."><given-names>A.</given-names> <surname>Duprey</surname></string-name>, <string-name name-style="western" hwp:sortable="Choi J."><given-names>J.</given-names> <surname>Choi</surname></string-name>, <article-title hwp:id="article-title-19">How the PhoP/PhoQ System Controls Virulence and Mg(2+) Homeostasis: Lessons in Signal Transduction, Pathogenesis, Physiology, and Evolution</article-title>. <source hwp:id="source-18">Microbiol Mol Biol Rev</source> <volume>85</volume>, <fpage>e0017620</fpage> (<year>2021</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Snyder S."><given-names>S.</given-names> <surname>Snyder</surname></string-name>, <string-name name-style="western" hwp:sortable="Kim D."><given-names>D.</given-names> <surname>Kim</surname></string-name>, <string-name name-style="western" hwp:sortable="McIntosh T. J."><given-names>T. J.</given-names> <surname>McIntosh</surname></string-name>, <article-title hwp:id="article-title-20">Lipopolysaccharide Bilayer Structure: Effect of Chemotype, Core Mutations, Divalent Cations, and Temperature</article-title>. <source hwp:id="source-19">Biochemistry</source> <volume>38</volume>, <fpage>10758</fpage>–<lpage>10767</lpage> (<year>1999</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Garidel P."><given-names>P.</given-names> <surname>Garidel</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-21">Divalent cations affect chain mobility and aggregate structure of lipopolysaccharide from Salmonella minnesota reflected in a decrease of its biological activity</article-title>. <source hwp:id="source-20">Biochim Biophys Acta</source> <volume>1715</volume>, <fpage>122</fpage>–<lpage>131</lpage> (<year>2005</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Henderson J. C."><given-names>J. C.</given-names> <surname>Henderson</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-22">The Power of Asymmetry: Architecture and Assembly of the Gram-Negative Outer Membrane Lipid Bilayer</article-title>. <source hwp:id="source-21">Annual Review of Microbiology</source> <volume>70</volume>, <fpage>255</fpage>–<lpage>278</lpage> (<year>2016</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2 xref-ref-22-3 xref-ref-22-4 xref-ref-22-5 xref-ref-22-6 xref-ref-22-7 xref-ref-22-8 xref-ref-22-9"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Kang K. N."><given-names>K. N.</given-names> <surname>Kang</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-23">Colistin heteroresistance in Enterobacter cloacae is regulated by PhoPQ-dependent 4-amino-4-deoxy-l-arabinose addition to lipid A</article-title>. <source hwp:id="source-22">Mol Microbiol</source> <volume>111</volume>, <fpage>1604</fpage>–<lpage>1616</lpage> (<year>2019</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Mitrophanov A. Y."><given-names>A. Y.</given-names> <surname>Mitrophanov</surname></string-name>, <string-name name-style="western" hwp:sortable="Jewett M. W."><given-names>M. W.</given-names> <surname>Jewett</surname></string-name>, <string-name name-style="western" hwp:sortable="Hadley T. J."><given-names>T. J.</given-names> <surname>Hadley</surname></string-name>, <string-name name-style="western" hwp:sortable="Groisman E. A."><given-names>E. A.</given-names> <surname>Groisman</surname></string-name>, <article-title hwp:id="article-title-24">Evolution and Dynamics of Regulatory Architectures Controlling Polymyxin B Resistance in Enteric Bacteria</article-title>. <source hwp:id="source-23">PLOS Genetics</source> <volume>4</volume>, <fpage>e1000233</fpage> (<year>2008</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Bishop R. E."><given-names>R. E.</given-names> <surname>Bishop</surname></string-name>, <string-name name-style="western" hwp:sortable="Kim S. H."><given-names>S. H.</given-names> <surname>Kim</surname></string-name>, <string-name name-style="western" hwp:sortable="El Zoeiby A."><given-names>A.</given-names> <surname>El Zoeiby</surname></string-name>, <article-title hwp:id="article-title-25">Role of lipid A palmitoylation in bacterial pathogenesis</article-title>. <source hwp:id="source-24">J Endotoxin Res</source> <volume>11</volume>, <fpage>174</fpage>–<lpage>180</lpage> (<year>2005</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Lippa A. M."><given-names>A. M.</given-names> <surname>Lippa</surname></string-name>, <string-name name-style="western" hwp:sortable="Goulian M."><given-names>M.</given-names> <surname>Goulian</surname></string-name>, <article-title hwp:id="article-title-26">Feedback Inhibition in the PhoQ/PhoP Signaling System by a Membrane Peptide</article-title>. <source hwp:id="source-25">PLOS Genetics</source> <volume>5</volume>, <fpage>e1000788</fpage> (<year>2009</year>).</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Soncini F. C."><given-names>F. C.</given-names> <surname>Soncini</surname></string-name>, <string-name name-style="western" hwp:sortable="Véscovi E. G."><given-names>E. G.</given-names> <surname>Véscovi</surname></string-name>, <string-name name-style="western" hwp:sortable="Groisman E. A."><given-names>E. A.</given-names> <surname>Groisman</surname></string-name>, <article-title hwp:id="article-title-27">Transcriptional autoregulation of the Salmonella typhimurium phoPQ operon</article-title>. <source hwp:id="source-26">Journal of Bacteriology</source> <volume>177</volume>, <fpage>4364</fpage>–<lpage>4371</lpage> (<year>1995</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Gunn J. S."><given-names>J. S.</given-names> <surname>Gunn</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-28">PmrA–PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance</article-title>. <source hwp:id="source-27">Molecular Microbiology</source> <volume>27</volume>, <fpage>1171</fpage>–<lpage>1182</lpage> (<year>1998</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Jia W."><given-names>W.</given-names> <surname>Jia</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-29">Lipid trafficking controls endotoxin acylation in outer membranes of Escherichia coli</article-title>. <source hwp:id="source-28">J Biol Chem</source> <volume>279</volume>, <fpage>44966</fpage>–<lpage>44975</lpage> (<year>2004</year>).</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Hwang P. M."><given-names>P. M.</given-names> <surname>Hwang</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-30">Solution structure and dynamics of the outer membrane enzyme PagP by NMR</article-title>. <source hwp:id="source-29">Proceedings of the National Academy of Sciences</source> <volume>99</volume>, <fpage>13560</fpage>–<lpage>13565</lpage> (<year>2002</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Bishop R. E."><given-names>R. E.</given-names> <surname>Bishop</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-31">Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria</article-title>. <source hwp:id="source-30">The EMBO Journal</source> <volume>19</volume>, <fpage>5071</fpage>–<lpage>5080</lpage> (<year>2000</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Malinverni J. C."><given-names>J. C.</given-names> <surname>Malinverni</surname></string-name>, <string-name name-style="western" hwp:sortable="Silhavy T. J."><given-names>T. J.</given-names> <surname>Silhavy</surname></string-name>, <article-title hwp:id="article-title-32">An ABC transport system that maintains lipid asymmetry in the gram-negative outer membrane</article-title>. <source hwp:id="source-31">Proc Natl Acad Sci U S A</source> <volume>106</volume>, <fpage>8009</fpage>–<lpage>8014</lpage> (<year>2009</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Bader M. W."><given-names>M. W.</given-names> <surname>Bader</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-33">Recognition of Antimicrobial Peptides by a Bacterial Sensor Kinase</article-title>. <source hwp:id="source-32">Cell</source> <volume>122</volume>, <fpage>461</fpage>–<lpage>472</lpage> (<year>2005</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Ramage B."><given-names>B.</given-names> <surname>Ramage</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-34">Comprehensive Arrayed Transposon Mutant Library of Klebsiella pneumoniae Outbreak Strain KPNIH1</article-title>. <source hwp:id="source-33">Journal of Bacteriology</source> <volume>199</volume>, <fpage>e00352</fpage>–<lpage>00317</lpage> (<year>2017</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Trent M. S."><given-names>M. S.</given-names> <surname>Trent</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-35">Accumulation of a polyisoprene-linked amino sugar in polymyxin-resistant Salmonella typhimurium and Escherichia coli: structural characterization and transfer to lipid A in the periplasm</article-title>. <source hwp:id="source-34">J Biol Chem</source> <volume>276</volume>, <fpage>43132</fpage>–<lpage>43144</lpage> (<year>2001</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Wilke K. E."><given-names>K. E.</given-names> <surname>Wilke</surname></string-name>, <string-name name-style="western" hwp:sortable="Francis S."><given-names>S.</given-names> <surname>Francis</surname></string-name>, <string-name name-style="western" hwp:sortable="Carlson E. E."><given-names>E. E.</given-names> <surname>Carlson</surname></string-name>, <article-title hwp:id="article-title-36">Inactivation of Multiple Bacterial Histidine Kinases by Targeting the ATP-Binding Domain</article-title>. <source hwp:id="source-35">ACS Chemical Biology</source> <volume>10</volume>, <fpage>328</fpage>–<lpage>335</lpage> (<year>2015</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Thielen M. K."><given-names>M. K.</given-names> <surname>Thielen</surname></string-name>, <string-name name-style="western" hwp:sortable="Vaneerd C. K."><given-names>C. K.</given-names> <surname>Vaneerd</surname></string-name>, <string-name name-style="western" hwp:sortable="Goswami M."><given-names>M.</given-names> <surname>Goswami</surname></string-name>, <string-name name-style="western" hwp:sortable="Carlson E. E."><given-names>E. E.</given-names> <surname>Carlson</surname></string-name>, <string-name name-style="western" hwp:sortable="May J. F."><given-names>J. F.</given-names> <surname>May</surname></string-name>, <article-title hwp:id="article-title-37">2-Aminobenzothiazoles Inhibit Virulence Gene Expression and Block Polymyxin Resistance in Salmonella enterica</article-title>. <source hwp:id="source-36">Chembiochem</source> <volume>21</volume>, <fpage>3500</fpage>–<lpage>3503</lpage> (<year>2020</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Mercier R."><given-names>R.</given-names> <surname>Mercier</surname></string-name>, <string-name name-style="western" hwp:sortable="Kawai Y."><given-names>Y.</given-names> <surname>Kawai</surname></string-name>, <string-name name-style="western" hwp:sortable="Errington J."><given-names>J.</given-names> <surname>Errington</surname></string-name>, <article-title hwp:id="article-title-38">Excess Membrane Synthesis Drives a Primitive Mode of Cell Proliferation</article-title>. <source hwp:id="source-37">Cell</source> <volume>152</volume>, <fpage>997</fpage>–<lpage>1007</lpage> (<year>2013</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Billings G."><given-names>G.</given-names> <surname>Billings</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-39">De novo morphogenesis in L-forms via geometric control of cell growth</article-title>. <source hwp:id="source-38">Molecular Microbiology</source> <volume>93</volume>, <fpage>883</fpage>–<lpage>896</lpage> (<year>2014</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Rojas E. R."><given-names>E. R.</given-names> <surname>Rojas</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-40">The outer membrane is an essential load-bearing element in Gram-negative bacteria</article-title>. <source hwp:id="source-39">Nature</source> <volume>559</volume>, <fpage>617</fpage>–<lpage>621</lpage> (<year>2018</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Poirel L."><given-names>L.</given-names> <surname>Poirel</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-41">The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae</article-title>. <source hwp:id="source-40">Journal of Antimicrobial Chemotherapy</source> <volume>70</volume>, <fpage>75</fpage>–<lpage>80</lpage> (<year>2014</year>).</citation></ref><ref id="c41" hwp:id="ref-41"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Cannatelli A."><given-names>A.</given-names> <surname>Cannatelli</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-42"><italic toggle="yes">In Vivo</italic> Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP <italic toggle="yes">mgrB</italic> Regulator</article-title>. <source hwp:id="source-41">Antimicrobial Agents and Chemotherapy</source> <volume>57</volume>, <fpage>5521</fpage>–<lpage>5526</lpage> (<year>2013</year>).</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Lopez-Camacho E."><given-names>E.</given-names> <surname>Lopez-Camacho</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-43">Genomic analysis of the emergence and evolution of multidrug resistance during a Klebsiella pneumoniae outbreak including carbapenem and colistin resistance</article-title>. <source hwp:id="source-42">J Antimicrob Chemother</source> <volume>69</volume>, <fpage>632</fpage>–<lpage>636</lpage> (<year>2014</year>).</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Roberts D."><given-names>D.</given-names> <surname>Roberts</surname></string-name>, <string-name name-style="western" hwp:sortable="Higgs E."><given-names>E.</given-names> <surname>Higgs</surname></string-name>, <string-name name-style="western" hwp:sortable="Rutman A."><given-names>A.</given-names> <surname>Rutman</surname></string-name>, <string-name name-style="western" hwp:sortable="Cole P."><given-names>P.</given-names> <surname>Cole</surname></string-name>, <article-title hwp:id="article-title-44">Isolation of spheroplastic forms of Haemophilus influenzae from sputum in conventionally treated chronic bronchial sepsis using selective medium supplemented with N-acetyl-D-glucosamine: possible reservoir for re-emergence of infection</article-title>. <source hwp:id="source-43">Br Med J (Clin Res Ed)</source> <volume>289</volume>, <fpage>1409</fpage>–<lpage>1412</lpage> (<year>1984</year>).</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Davies B. W."><given-names>B. W.</given-names> <surname>Davies</surname></string-name>, <string-name name-style="western" hwp:sortable="Bogard R. W."><given-names>R. W.</given-names> <surname>Bogard</surname></string-name>, <string-name name-style="western" hwp:sortable="Mekalanos J. J."><given-names>J. J.</given-names> <surname>Mekalanos</surname></string-name>, <article-title hwp:id="article-title-45">Mapping the regulon of Vibrio cholerae ferric uptake regulator expands its known network of gene regulation</article-title>. <source hwp:id="source-44">Proc Natl Acad Sci U S A</source> <volume>108</volume>, <fpage>12467</fpage>–<lpage>12472</lpage> (<year>2011</year>).</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>45.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Boll J. M."><given-names>J. M.</given-names> <surname>Boll</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-46">A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient <italic toggle="yes">Acinetobacter baumannii</italic></article-title>. <source hwp:id="source-45">Proceedings of the National Academy of Sciences</source> <volume>113</volume>, <fpage>E6228</fpage>–<lpage>E6237</lpage> (<year>2016</year>).</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Livak K. J."><given-names>K. J.</given-names> <surname>Livak</surname></string-name>, <string-name name-style="western" hwp:sortable="Schmittgen T. D."><given-names>T. D.</given-names> <surname>Schmittgen</surname></string-name>, <article-title hwp:id="article-title-47">Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method</article-title>. <source hwp:id="source-46">Methods</source> <volume>25</volume>, <fpage>402</fpage>–<lpage>408</lpage> (<year>2001</year>).</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>47.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Guérin F."><given-names>F.</given-names> <surname>Guérin</surname></string-name>, <string-name name-style="western" hwp:sortable="Isnard C."><given-names>C.</given-names> <surname>Isnard</surname></string-name>, <string-name name-style="western" hwp:sortable="Cattoir V."><given-names>V.</given-names> <surname>Cattoir</surname></string-name>, <string-name name-style="western" hwp:sortable="Giard J. C."><given-names>J. C.</given-names> <surname>Giard</surname></string-name>, <article-title hwp:id="article-title-48">Complex Regulation Pathways of AmpC-Mediated β-Lactam Resistance in Enterobacter cloacae Complex</article-title>. <source hwp:id="source-47">Antimicrobial Agents and Chemotherapy</source> <volume>59</volume>, <fpage>7753</fpage>–<lpage>7761</lpage> (<year>2015</year>).</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><label>48.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Huang T. W."><given-names>T. W.</given-names> <surname>Huang</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-49">Capsule deletion via a lambda-Red knockout system perturbs biofilm formation and fimbriae expression in Klebsiella pneumoniae MGH 78578</article-title>. <source hwp:id="source-48">BMC Res Notes</source> <volume>7</volume>, <fpage>13</fpage> (<year>2014</year>).</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1 xref-ref-49-2"><label>49.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Datsenko K. A."><given-names>K. A.</given-names> <surname>Datsenko</surname></string-name>, <string-name name-style="western" hwp:sortable="Wanner B. L."><given-names>B. L.</given-names> <surname>Wanner</surname></string-name>, <article-title hwp:id="article-title-50">One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title>. <source hwp:id="source-49">Proc Natl Acad Sci U S A</source> <volume>97</volume>, <fpage>6640</fpage>–<lpage>6645</lpage> (<year>2000</year>).</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1 xref-ref-50-2"><label>50.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.50" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Lazarus J. E."><given-names>J. E.</given-names> <surname>Lazarus</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-51">A New Suite of Allelic-Exchange Vectors for the Scarless Modification of Proteobacterial Genomes</article-title>. <source hwp:id="source-50">Appl Environ Microbiol</source> <volume>85</volume> (<year>2019</year>).</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><label>51.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Gibson D. G."><given-names>D. G.</given-names> <surname>Gibson</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-52">Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title>. <source hwp:id="source-51">Nature Methods</source> <volume>6</volume>, <fpage>343</fpage>–<lpage>345</lpage> (<year>2009</year>).</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><label>52.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.52" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Kang K. N."><given-names>K. N.</given-names> <surname>Kang</surname></string-name> <etal>et al.</etal>, <article-title hwp:id="article-title-53">Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii</article-title>. <source hwp:id="source-52">mBio</source> <volume>12</volume> (<year>2021</year>).</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><label>53.</label><citation publication-type="journal" citation-type="journal" ref:id="2021.09.25.461800v2.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Zhou Z."><given-names>Z.</given-names> <surname>Zhou</surname></string-name>, <string-name name-style="western" hwp:sortable="Lin S."><given-names>S.</given-names> <surname>Lin</surname></string-name>, <string-name name-style="western" hwp:sortable="Cotter R. J."><given-names>R. J.</given-names> <surname>Cotter</surname></string-name>, <string-name name-style="western" hwp:sortable="Raetz C. R."><given-names>C. R.</given-names> <surname>Raetz</surname></string-name>, <article-title hwp:id="article-title-54">Lipid A modifications characteristic of Salmonella typhimurium are induced by NH4VO3 in Escherichia coli K12. Detection of 4-amino-4-deoxy-L-arabinose, phosphoethanolamine and palmitate</article-title>. <source hwp:id="source-53">J Biol Chem</source> <volume>274</volume>, <fpage>18503</fpage>–<lpage>18514</lpage> (<year>1999</year>).</citation></ref></ref-list></back></article>
